Early Development and Diagnostic Trajectories in DCD

NCT ID: NCT05617586

Last Updated: 2022-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-15

Study Completion Date

2022-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to map the early development of children with DCD and the diagnostic trajectory in Flanders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Diagnostic and Statistical manual 5th edition (DSM-V) defines Developmental Coordination Disorder (DCD) as early-onset deficits in acquiring and executing motor coordination skills. These deficits significantly interfere with the performance of activities of daily living and impact on academic productivity, leisure and play.

Although DCD can be identified during preschool, diagnosis generally occurs at primary-school age. Before the age of three (t.i. infancy), some parents already express "something is wrong" with their child albeit DCD is rarely diagnosed within this age-group.

Knowledge on DCD in children before the age of five is limited. The aim of this study is twofold: to explore the early development of children with DCD and to map the diagnostic trajectory of DCD in Flanders.

Design: A qualitative narrative inductive study design by means of audio-recorded in-depth interviews

Sampling: Purposeful maximum variation sampling will be applied.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Developmental Coordination Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DCD Parents

An in-depth interview will be conducted of parents of a child with DCD. Parents will be asked to complete a Developmental Coordination Disorder Questionnaire (DCD-Q).

In-depth parental interview

Intervention Type OTHER

A semi-structurerd interview will be conducted of parents with a child diagnosed with DCD. The interview will be audio-recorderded. The audiofile will be transcribed ad-verbatim and analyzed using narrative analysis methods.

Developmental Coordination Disorder Questionnaire (DCD-Q)

Intervention Type OTHER

Parents will be asked to complete the DCD-Q. This will help us describe the sample.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

In-depth parental interview

A semi-structurerd interview will be conducted of parents with a child diagnosed with DCD. The interview will be audio-recorderded. The audiofile will be transcribed ad-verbatim and analyzed using narrative analysis methods.

Intervention Type OTHER

Developmental Coordination Disorder Questionnaire (DCD-Q)

Parents will be asked to complete the DCD-Q. This will help us describe the sample.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Parent or guardian of a child diagnosed with DCD
2. Diagnosis of DCD within the last two years
3. Child was max. 12y of age at the moment of DCD diagnosis

Exclusion Criteria

1. No severe diseases in early childhood greatly impacting development (cancer, severe accident,…)
2. Diagnosis outside of Belgium
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amy De Roubaix, Master

Role: PRINCIPAL_INVESTIGATOR

University Ghent

Hilde Van Waelvelde, PhD

Role: STUDY_CHAIR

University Ghent

Dominique Van De Velde, PhD

Role: STUDY_CHAIR

University Ghent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ghent University

Ghent, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B670201836914

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.